Type I collagen synthesis (None (since this is not a canonical molecular target but a process).)

"Type I collagen synthesis" refers to the complex intracellular and extracellular pathway responsible for biosynthesis of type I collagen, the primary structural protein in connective tissues such as bone, skin, tendon, and cornea[1][3][4][5]. The process involves transcription of the COL1A1 and COL1A2 genes, translation of pro-alpha chains on ribosomes, post-translational modifications (hydroxylation and glycosylation), triple helix formation, secretion, extracellular cleavage of propeptides, and hierarchical assembly into fibrils and fibers[1][3]. Proper synthesis requires vitamin C as a cofactor, and defects or deficiencies lead to disorders such as osteogenesis imperfecta, Ehlers-Danlos syndrome, and scurvy[1][3][4][5]. While not a single molecular drug target, the enzymes and co-factors involved in this pathway are sometimes therapeutically targeted in fibrosis, wound healing, or tissue regeneration studies.

Other names

Type I collagen formationcollagen type I biosynthesiscollagen I synthesis

Ascorbic acid promotes prolyl and lysyl hydroxylation during collagen synthesis Antifibrotic drugs reduce transcription or translation of collagen genes, or inhibit key enzymes in the synthesis pathway